Lucy Shapiro
CIK 1435944 · last filed 2025-06-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.9K
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$17.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-19 | PACB | Grant (A) | — | $0 | EDGAR |
| 2016-01-26 | PACB | Exer (M) | +101,666 | $338.8K | EDGAR |
| 2015-06-11 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | +794 | $0 | EDGAR |
| 2015-05-21 | PACB | Grant (A) | — | $0 | EDGAR |
| 2014-12-29 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Gift (G) | −28,000 | $0 | EDGAR |
| 2014-12-12 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Mixed | −182,664 | -$8.91M | EDGAR |
| 2014-03-25 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Sell (S) | −80,000 | -$1.69M | EDGAR |
| 2014-02-21 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-06-12 | PACB | Grant (A) | — | $0 | EDGAR |
| 2013-06-07 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.